HR
USNA icon

Howe & Rusling’s Usana Health Sciences USNA Stock Holding History

Howe & Rusling’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,360
Closed -$92K – 939
2014
Q2 		$92K Buy
2,360
+960
+69% +$35.6K 0.02% 231
2014
Q1 		$53K Hold
1,400
– – 0.01% 316
2013
Q4 		$53K Hold
1,400
– – 0.01% 293
2013
Q3 		$61K Buy
+1,400
New +$56.2K 0.02% 287

Other funds holding USNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Howe & Rusling's USNA Position: Q3 2014 in Review

Howe & Rusling sold out of Usana Health Sciences (USNA) in Q3 2014, closing a stake of 2,360 shares — an estimated $92K sold.

Howe & Rusling first reported a position in USNA in Q3 2013 and held it in 4 quarters. The position peaked at $92K in Q2 2014. 124 funds tracked by Wall St. Rank hold USNA as of Q3 2014.

  • Howe & Rusling reported no remaining Usana Health Sciences position as of Q3 2014 after selling out during the quarter.
  • Howe & Rusling sold 2,360 Usana Health Sciences shares in Q3 2014, an estimated $92K.
  • Howe & Rusling first reported a position in Usana Health Sciences in Q3 2013 and held it in 4 quarters.
  • Howe & Rusling's Usana Health Sciences position peaked at $92K in Q2 2014.
  • 124 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2014.

Based on Howe & Rusling's 13F filing for Q3 2014, filed 31 Oct 2014.